BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11432744)

  • 1. Oxidative folding of murine prion mPrP(23-231).
    Lu BY; Beck PJ; Chang JY
    Eur J Biochem; 2001 Jul; 268(13):3767-73. PubMed ID: 11432744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3-disulfide mutant of mouse prion protein expression, oxidative folding, reductive unfolding, conformational stability, aggregation and isomerization.
    Lu BY; Chang JY
    Arch Biochem Biophys; 2007 Apr; 460(1):75-84. PubMed ID: 17320038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a polymerized prion protein.
    Lu BY; Chang JY
    Biochem J; 2002 May; 364(Pt 1):81-7. PubMed ID: 11988079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature.
    Martins SM; Chapeaurouge A; Ferreira ST
    J Biol Chem; 2003 Dec; 278(50):50449-55. PubMed ID: 14525996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold destabilization and temperature jump of the murine prion protein mPrP(23-231).
    Matsumoto T; Nakagawa T; Kuwata K
    Biochim Biophys Acta; 2009 Apr; 1794(4):669-73. PubMed ID: 19336039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties.
    Lu BY; Chang JY
    Biochemistry; 2001 Nov; 40(44):13390-6. PubMed ID: 11683649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible aggregation of mouse prion protein derivatives with PrPSC-like structural properties.
    Lu BY; Atanasov I; Zhou ZH; Chang JY
    J Protein Chem; 2003 Feb; 22(2):115-26. PubMed ID: 12760416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization.
    Hornemann S; Korth C; Oesch B; Riek R; Wider G; Wüthrich K; Glockshuber R
    FEBS Lett; 1997 Aug; 413(2):277-81. PubMed ID: 9280297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The residual pro-part of cathepsin C fulfills the criteria required for an intramolecular chaperone in folding and stabilizing the human proenzyme.
    Cigić B; Dahl SW; Pain RH
    Biochemistry; 2000 Oct; 39(40):12382-90. PubMed ID: 11015218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
    Prion; 2012; 6(5):489-97. PubMed ID: 22987112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
    Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
    PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein mPrP[F175A](121-231): structure and stability in solution.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2012 Nov; 423(4):496-502. PubMed ID: 22922482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding and oxidation of recombinant human stem cell factor produced in Escherichia coli.
    Jones MD; Narhi LO; Chang WC; Lu HS
    J Biol Chem; 1996 May; 271(19):11301-8. PubMed ID: 8626682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
    Morillas M; Vanik DL; Surewicz WK
    Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of disulfide bridge in the folding and stability of the recombinant human prion protein.
    Maiti NR; Surewicz WK
    J Biol Chem; 2001 Jan; 276(4):2427-31. PubMed ID: 11069909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state.
    Zhang JG; Matthews JM; Ward LD; Simpson RJ
    Biochemistry; 1997 Mar; 36(9):2380-9. PubMed ID: 9054543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies.
    Cardamone M; Puri NK; Brandon MR
    Biochemistry; 1995 May; 34(17):5773-94. PubMed ID: 7727438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disulfide folding pathway of potato carboxypeptidase inhibitor.
    Chang JY; Canals F; Schindler P; Querol E; Avilés FX
    J Biol Chem; 1994 Sep; 269(35):22087-94. PubMed ID: 8071332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.